MRI Assessment of Hepatocellular Carcinoma After Locoregional Therapy

Insights into Imaging - Germany
doi 10.1186/s13244-019-0690-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Locoregional and Systemic Therapy for Hepatocellular Carcinoma

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2017English

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Encouraging but Insufficient

HepatoBiliary Surgery and Nutrition
2018English

Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times

2011English

Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-Based Review

Journal of Clinical and Translational Hepatology
2018English

Hepatocellular Carcinoma Risk After Direct-Acting Antiviral Therapy

Clinical Liver Disease
Hepatology
2019English

MRI in Detection of Hepatocellular Carcinoma (HCC)

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2005English

Role of MRI in Assessment of Hepatocellular Carcinoma (HCC) After TACE (Trans-Arterial Chemoembolization) With Persistent High Alfa Fetoprotein (AFP)

The Egyptian Journal of Hospital Medicine
2018English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Targeted Therapy in Hepatocellular Carcinoma

International Journal of Hepatology
Hepatology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy